First Header Logo Second Header Logo

Connection

Nancy King to Informed Consent

This is a "connection" page, showing publications Nancy King has written about Informed Consent.
Connection Strength

4.330
  1. King NMP. Key Information in the New Common Rule: Can It Save Research Consent? J Law Med Ethics. 2019 06; 47(2):203-212.
    View in: PubMed
    Score: 0.674
  2. King NMP, Bishop CE. How Should Physicians Help Patients Understand Unknowns of Nanoparticle-Based Medicines? AMA J Ethics. 2019 04 01; 21(4):E324-331.
    View in: PubMed
    Score: 0.666
  3. Robeson R, King NM. Loss of possession: concussions, informed consent, and autonomy. J Law Med Ethics. 2014; 42(3):334-43.
    View in: PubMed
    Score: 0.463
  4. King NM, Robeson R. Athletes are Guinea pigs. Am J Bioeth. 2013; 13(10):13-4.
    View in: PubMed
    Score: 0.432
  5. King NM. There's a lot we don't know (and we ought to say so). Am J Bioeth. 2013; 13(12):20-1.
    View in: PubMed
    Score: 0.432
  6. King NM. Nanomedicine first-in-human research: challenges for informed consent. J Law Med Ethics. 2012; 40(4):823-30.
    View in: PubMed
    Score: 0.403
  7. Andrews JE, Moore JB, Weinberg RB, Sissine M, Gesell S, Halladay J, Rosamond W, Bushnell C, Jones S, Means P, King NMP, Omoyeni D, Duncan PW. Ensuring respect for persons in COMPASS: a cluster randomised pragmatic clinical trial. J Med Ethics. 2018 08; 44(8):560-566.
    View in: PubMed
    Score: 0.156
  8. Shepherd L, Macklin R, King NM, Dreger A, Wages NA. Informed Consent for Research on Medical Practices. Ann Intern Med. 2015 Nov 03; 163(9):725.
    View in: PubMed
    Score: 0.132
  9. Baker HB, McQuilling JP, King NM. Ethical considerations in tissue engineering research: Case studies in translation. Methods. 2016 Apr 15; 99:135-44.
    View in: PubMed
    Score: 0.130
  10. Macklin R, Shepherd L, Dreger A, Asch A, Baylis F, Brody H, Churchill LR, Coleman CH, Cowan E, Dolgin J, Downie J, Dresser R, Elliott C, Epright MC, Feder EK, Glantz LH, Grodin MA, Hoffman W, Hoffmaster B, Hunter D, Iltis AS, Kahn JD, King NM, Kraft R, Kukla R, Leavitt L, Lederer SE, Lemmens T, Lindemann H, Marshall MF, Merz JF, Miller FH, Mohrmann ME, Morreim H, Nass M, Nelson JL, Noble JH, Reis E, Reverby SM, Silvers A, Sousa AC, Spece RG, Strong C, Swazey JP, Turner L. The OHRP and SUPPORT--another view. N Engl J Med. 2013 Jul 11; 369(2):e3.
    View in: PubMed
    Score: 0.112
  11. Churchill LR, King NM, Henderson GE. Why we should continue to worry about the therapeutic misconception. J Clin Ethics. 2013; 24(4):381-6.
    View in: PubMed
    Score: 0.108
  12. King NM, Henderson G. Treatments of last resort: informed consent and the diffusion of new technology. Mercer Law Rev. 1991; 42(3):1007-50.
    View in: PubMed
    Score: 0.094
  13. Hall MA, King NM, Perdue LH, Hilner JE, Akolkar B, Greenbaum CJ, McKeon C. Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Clin Trials. 2010; 7(1 Suppl):S33-45.
    View in: PubMed
    Score: 0.088
  14. Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, Kass N, King NM, Lidz CW, Miller FG, Nelson DK, Peppercorn J, Rothschild BB, Sankar P, Wilfond BS, Zimmer CR. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med. 2007 Nov 27; 4(11):e324.
    View in: PubMed
    Score: 0.076
  15. Kipnis K, King NM, Nelson RM. An open letter to institutional review boards considering Northfield Laboratories' PolyHeme trial. Am J Bioeth. 2006 May-Jun; 6(3):18-21.
    View in: PubMed
    Score: 0.068
  16. Kipnis K, King NM, Nelson RM. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver. IRB. 2006 Mar-Apr; 28(2):16-9.
    View in: PubMed
    Score: 0.067
  17. Henderson GE, Easter MM, Zimmer C, King NM, Davis AM, Rothschild BB, Churchill LR, Wilfond BS, Nelson DK. Therapeutic misconception in early phase gene transfer trials. Soc Sci Med. 2006 Jan; 62(1):239-53.
    View in: PubMed
    Score: 0.064
  18. King NM. The line between clinical innovation and human experimentation. Seton Hall Law Rev. 2003; 32(3):571-80.
    View in: PubMed
    Score: 0.054
  19. King NM. Health policy--ensuring informed consent in human experimentation: a comparison of the approaches of two states. North Carol Law Rev. 1979 Oct; 58(1):137-52.
    View in: PubMed
    Score: 0.043
  20. Bailey DB, Gehtland LM, Lewis MA, Peay H, Raspa M, Shone SM, Taylor JL, Wheeler AC, Cotten M, King NMP, Powell CM, Biesecker B, Bishop CE, Boyea BL, Duparc M, Harper BA, Kemper AR, Lee SN, Moultrie R, Okoniewski KC, Paquin RS, Pettit D, Porter KA, Zimmerman SJ. Early Check: translational science at the intersection of public health and newborn screening. BMC Pediatr. 2019 07 17; 19(1):238.
    View in: PubMed
    Score: 0.042
  21. Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M. What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. J Law Med Ethics. 2012; 40(4):1008-24.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.